Literature DB >> 11298487

Therapeutic relevance of altered cytokine expression.

K M Kulmatycki1, F Jamali.   

Abstract

Cytokines and their receptors have numerous physiological functions. Altered concentrations of these mediators are associated with various afflictions. For example, over-expression of cytokines has been associated with altered drug concentrations and activity. Greater concentrations of cardiovascular drugs have been observed in humans and laboratory animals with various types of inflammatory disorders compared to healthy controls. Interestingly, the observed higher concentrations of drugs such as propranolol and verapamil have not been associated with increased effects. Indeed, reduced response to these cardiovascular drugs is observed, suggestive of cytokine-mediated downregulation of receptors. Increased cytokine concentrations have also been associated with decreased response to drugs used in treatment of other disorders such as AIDS, asthma and psychiatric diseases. This reduced response to drug in the presence of altered cytokine concentrations is especially relevant to the elderly population which has a greater incidence of multiple diseases and elevated concentrations of various cytokines compared to younger individuals. Furthermore, inflammatory conditions and their accompanied increased over-expression of cytokines are suggested to be the main determinants of therapeutic failure in myocardial infarction and angina. Therefore, altered cytokine concentrations may influence therapeutic outcomes of pharmacotherapy and result in treatment failure. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11298487     DOI: 10.1006/cyto.2000.0827

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  8 in total

1.  Drug-disease interactions: reduced beta-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat.

Authors:  K M Kulmatycki; K Abouchehade; S Sattari; F Jamali
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Cardiovascular effect of inflammation and nonsteroidal anti-inflammatory drugs on renin-angiotensin system in experimental arthritis.

Authors:  Waheed Asghar; Ali Aghazadeh-Habashi; Fakhreddin Jamali
Journal:  Inflammopharmacology       Date:  2017-04-07       Impact factor: 4.473

3.  The effect of the neutrophil elastase inhibitor sivelestat on early injury after liver resection.

Authors:  Shigehiro Tsujii; Takehiro Okabayashi; Mai Shiga; Yuka Takezaki; Takeki Sugimoto; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

4.  Predicting the toxicity of weekly docetaxel in advanced cancer.

Authors:  Kellie A Charles; Laurent P Rivory; Martin R Stockler; Philip Beale; Jane Beith; Michael Boyer; Stephen J Clarke
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

5.  Despite increased plasma concentration, inflammation reduces potency of calcium channel antagonists due to lower binding to the rat heart.

Authors:  Saeed Sattari; William F Dryden; Lise A Eliot; Fakhreddin Jamali
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 6.  Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities.

Authors:  Madeline L Pfau; Caroline Ménard; Scott J Russo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2017-10-06       Impact factor: 13.820

7.  Dose-dependency of the cardiovascular risks of non-steroidal anti-inflammatory drugs.

Authors:  Surur Ali Ahmed; Hanan Al-Lawati; Fakhreddin Jamali
Journal:  Inflammopharmacology       Date:  2019-07-29       Impact factor: 5.093

8.  Serial changes in plasma levels of cytokines in patients with coronary artery disease.

Authors:  Roberto H Heinisch; Carlos R Zanetti; Fabiano Comin; Juliano L Fernandes; José A Ramires; Carlos V Serrano
Journal:  Vasc Health Risk Manag       Date:  2005
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.